Year: 2018
Type: article
Abstract: Basic leucine zipper transcription factor 2 (Batf2) activation is detrimental in Type 1-controlled infectious diseases, demonstrated during infection with Mycobacterium tuberculosis (Mtb) and Listeria monocytogenes Lm. In Batf2 -deficient mice (Batf2 −/− ), infected with Mtb or Lm, mice survived and displayed reduced tissue pathology compared to infected control mice. Indeed, pulmonary inflammatory macrophage recruitment, pro-inflammatory cytokines and immune effectors were also decreased during tuberculosis. This explains that batf2 mRNA predictive early biomarker found in active TB patients is increased in peripheral blood. Similarly, Lm infection in human macrophages and mouse spleen and liver also increased Batf2 expression. In striking contrast, Type 2-controlled schistosomiasis exacerbates during infected Batf2 −/− mice with increased intestinal fibro-granulomatous inflammation, pro-fibrotic immune cells, and elevated cytokine production leading to wasting disease and early death. Together, these data strongly indicate that Batf2 differentially regulates Type 1 and Type 2 immunity in infectious diseases.
Source: Mucosal Immunology
Authors: Reto Guler(Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization), Thabo Mpotje(Conceptualization, Formal analysis, Investigation, Methodology, Validation, Visualization), Mumin Ozturk(Conceptualization, Formal analysis, Investigation, Methodology, Validation, Visualization), Justin K. Nono(Conceptualization, Formal analysis, Investigation, Methodology, Project administration, Supervision, Validation, Visualization), Suraj P. Parihar(Conceptualization, Formal analysis, Investigation, Methodology, Project administration, Supervision, Validation, Visualization), Julius Ebua Chia(Formal analysis, Investigation, Methodology), Nada Abdel Aziz(Investigation, Methodology), Lerato Hlaka(Investigation, Methodology), Santosh Kumar(Investigation, Methodology), Sugata Roy(Investigation, Methodology), Adam Penn-Nicholson(Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization), Willem A. Hanekom(Conceptualization, Funding acquisition, Project administration, Resources, Supervision), Daniel E. Zak(Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization), Thomas J. Scriba(Conceptualization, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision), Harukazu Suzuki(Conceptualization, Funding acquisition, Project administration, Resources, Supervision), Frank Brombacher(Conceptualization, Funding acquisition, Project administration, Resources, Supervision)
Institutions: South African Medical Research Council, University of Cape Town, International Centre for Genetic Engineering and Biotechnology, Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Ministry of Scientific Research and Innovation, Institut de Recherches Médicales et d’Etudes des Plantes Médicinales, Cairo University, RIKEN Center for Integrative Medical Sciences, South African Tuberculosis Vaccine Initiative, Center for Infectious Disease Research
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,370
Funders: Carnegie Corporation of New York, Bill and Melinda Gates Foundation, Wellcome Trust, National Research Foundation, Claude Leon Foundation, Department of Science and Technology, Ministry of Science and Technology, India, National Institutes of Health, Japan Society for the Promotion of Science, Erasmus+, National Institute of Allergy and Infectious Diseases
Awards: G3022350929, Centre for Infectious Diseases Research in Africa (CIDRI-Africa), University of Cape Town - to identify predictive gene expression signatures of risk of tuberculosis (TB) disease, following natural infection with Mycobacterium tuberculosis..., Omics for TB Disease Progression (OTB), Host determinants of protection against tuberculosis in adolescents, Establishment of a Centre for Clinical Infectious Diseases Research at the University of Cape Town (Wellcome-UCT-CCIDR).
OpenAlex ID: W2905257572
